Tag: Pfizer

Finance

Healthcare Active Runners: Merck & Co. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Ariad Pharmaceuticals (NASDAQ:ARIA)

Merck & Co., Inc. (NYSE:MRK) is getting close to conducting phase 3 trials for a combination treatment for Hepatitis C, which could potentially rejuvenate the pharmaceutical giant’s revenue growth. The clinical data for a combination of drugs MK-5172 and MK-8742 has showed high cure rates among patients with genotype 1 of the disease, and this has encouraged Merck to move to phase 3 trials. Merck … Continue reading Healthcare Active Runners: Merck & Co. (NYSE:MRK), Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Ariad Pharmaceuticals (NASDAQ:ARIA)

Kevin Long
Finance

Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Inovio Pharmaceuticals (NYSEMKT:INO), Johnson & Johnson (NYSE:JNJ)

Pfizer Inc. (NYSE:PFE) announced encouraging top-line data from a phase IIIb study evaluating Genotropin for increasing height in small-for-gestational-age (SGA) children aged between 24 and 30 months. Pfizer Inc. (NYSE:PFE) stock performance was -0.25% in last session and finished the day at $32.10. Traded volume was 27.74million shares in the last session and the average volume of the stock remained 26.63million shares. The beta of … Continue reading Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Inovio Pharmaceuticals (NYSEMKT:INO), Johnson & Johnson (NYSE:JNJ)

Jayne Crisman
Finance

NYSE Active Stocks: Oracle Corporation (NYSE:ORCL), AT&T Inc. (NYSE:T), Pfizer Inc. (NYSE:PFE), Verizon Communications Inc. (NYSE:VZ)

Grupo Farmacos Especializados Determined Oracle Corporation (NYSE:ORCL) Engineered Systems to Be the Most Efficient, Cost-Effective Solution for Maintaining Business Growth Oracle Corporation (NYSE:ORCL) stock performance was 1.77% in last session and finished the day at $39.08. Traded volume was 31.36 million shares in the last session and the average volume of the stock remained 16.07 million shares. The beta of the stock remained 1.28. Oracle … Continue reading NYSE Active Stocks: Oracle Corporation (NYSE:ORCL), AT&T Inc. (NYSE:T), Pfizer Inc. (NYSE:PFE), Verizon Communications Inc. (NYSE:VZ)

Colin Pettis
Finance

Healthcare Most Active: Pfizer Inc. (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Pfizer Inc. (NYSE:PFE) announced that PROFILE 1014, a phase 3 study of anaplastic lymphoma kinase (ALK) inhibitor Xalkori (crizotinib), met its primary objective of significantly prolonging progression-free survival (PFS) in previously untreated patients with ALK-positive advanced non-squamous non-small cell lung cancer (NSCLC) when compared to standard platinum-based chemotherapy regimens. Pfizer Inc. (NYSE:PFE) stock performance was 1.13% in last session and finished the day at $32.18. … Continue reading Healthcare Most Active: Pfizer Inc. (NYSE:PFE), Bristol-Myers Squibb (NYSE:BMY), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Colin Pettis
FB Nasdaq FB Facebook
Finance

NYSE Active Runners: AT&T (NYSE:T), General Electric Company (NYSE:GE), Corning Incorporated (NYSE:GLW), Pfizer Inc. (NYSE:PFE)

AT&T, Inc. (NYSE:T) has turned on the nation’s most reliable 4G LTE network** in Traverse City, bringing customers the latest generation of wireless network technology. Those who live and work in Grand Traverse and Leelanau counties, including along M-37, M-22, U.S. Highway 31 and County Highway 611 will be most affected by the increased speed. AT&T, Inc. (NYSE:T) stock performance was 0.75% in last session … Continue reading NYSE Active Runners: AT&T (NYSE:T), General Electric Company (NYSE:GE), Corning Incorporated (NYSE:GLW), Pfizer Inc. (NYSE:PFE)

Colin Pettis
Finance

Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK)

Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Monday, May 5, 2014. Pfizer Inc. (NYSE:PFE) stock performance was 1.05% in last session and finished the day at $31.82. Traded volume was 21.09million shares in the last session and the average volume of the stock remained … Continue reading Healthcare Active Runners: Pfizer Inc. (NYSE:PFE), Gilead Sciences (NASDAQ:GILD), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK)

Jayne Crisman